Auro Laboratories

Auro Laboratories Current Ratio

The Current Ratio of Auro Laboratories (530233.BO) as of Oct 16, 2026 is 2.36. In the previous year, Current Ratio was 1.33 — a change of 77.28% (higher).

Current Ratio

2.36

YoY

77.28%

Last updated:

Current Ratio of Auro Laboratories is 2026 2.36 . Current Ratio of Auro Laboratories was 2025 1.33 . It decreases by 77.28% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Auro Laboratories Stock analysis

What does Auro Laboratories do? Auro Laboratories Ltd is a pharmaceutical company headquartered in Mumbai, India. The company engages in the manufacture of active pharmaceutical ingredients (APIs), intermediates, and generic formulations. It operates primarily within the Pharmaceuticals sector. Auro Laboratories offers APIs across various therapeutic categories, including antihistamines, muscle relaxants, diuretics, iron deficiency treatments, anti-diabetics, anti-fungals, anti-ulcer medications, iodine supplements, anti-malarials, analgesics, antacids, and anti-inflammatories. The company also produces intermediates such as Glibenclamide Sulphonamide, Cis-bromo benzoate, Cls-Tosylate, 2-Ethoxy Benzoic Acid, 3,4,5-Trimethoxy Benzoic Acid, and 5-Bromo Phthalide. Additionally, Auro Laboratories provides toll and custom manufacturing services for APIs and intermediates on a contract basis. The company has an international presence, with a significant portion of its production exported to Southeast Asia, the Middle East, and various European countries. Key export destinations include Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom. Auro Laboratories went public with its IPO on March 7, 1995. The company's website is http://www.aurolabs.com/. Auro Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Auro Laboratories stock

Current Ratio of Auro Laboratories is 2.36 in 2026.

Current Ratio of Auro Laboratories changed from 1.33 to 2.36, representing a 77.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Ratio Auro Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Auro Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Auro Laboratories

All Key Metrics — Auro Laboratories